Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 0 | 7 | 279 | 810 | 944 |
| Gross Profit | N/A | 7 | 279 | 810 | 944 |
| Operating Expenses | 32,823 | 23,215 | 12,810 | 6,478 | 1,578 |
| Operating Income | -32,823 | -23,208 | -12,531 | -5,668 | -634 |
| Other Income | 811 | -209 | 7 | -2 | -2 |
| Pre-tax Income | -32,012 | -23,416 | -12,524 | -5,670 | -637 |
| Income Tax | N/A | -28 | 28 | N/A | N/A |
| Net Income Continuous | -32,012 | -23,389 | -12,551 | -5,670 | -637 |
| Net Income | $-32,012 | $-23,389 | $-12,551 | $-5,670 | $-637 |
| EPS Basic Total Ops | -2.48 | -2.58 | -2.82 | -6.44 | -1.63 |
| EPS Basic Continuous Ops | -2.48 | -2.58 | -2.82 | -6.33 | -1.30 |
| EPS Diluted Total Ops | -2.48 | -2.58 | -2.82 | -6.44 | -1.63 |
| EPS Diluted Continuous Ops | -2.48 | -2.58 | -2.82 | -6.33 | -1.30 |
| EPS Diluted Before Non-Recurring Items | -2.48 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-32,729 | $-23,132 | $-12,505 | $-5,641 | $-585 |